|Position||Trades||Duration||Win rate||Win/loss||Avg win||Avg loss||Return|
|Position||Trades||Duration||Win Rate||Win/Loss||Avg Win||Avg Loss||Return|
CHAIKIN MONEY FLOW
Trading: SELL @ $0.51
Signal Strength: MEDIUM
Myx (ASX:MYX) current price has highlighted recent selling pressure and the continuation of a bearish trading conditions. Currently, the CMF is -0.07. MYX.AXThe bearish signal has been active for 0 day. During the quarter, the lowest CMF value was -0.14 occurring on the Jun 19 2019.
Indicator can be used in isolation or in additional to another technical indicator to confirmation for trading exit. Indicator can be applied to the short/medium term timeframe, but the best results are obtained with larger cyclical swings in-line with the trend direction. This accumulation / distribution oscillator can provide guidance on the money flow direction from the companies recent trading.
Developed by Marc Chaikin, Chaikin Money Flow measures the amount of Money Flow Volume over a specific period. Money Flow Volume forms the basis for the Accumulation Distribution Line. Instead of a cumulative total of Money Flow Volume, Chaikin Money Flow simply sums Money Flow Volume for a specific look-back period, typically 20 or 21 days. The resulting indicator fluctuates above/below the zero line just like an oscillator. Chartists weigh the balance of buying or selling pressure with the absolute level of Chaikin Money Flow. Chartists can also look for crosses above or below the zero line to identify changes on money flow.
Calculation: Chaikin Money Flow (20):
1) Money Flow Multiplier = [(Close - Low) - (High - Close)] / (High - Low);
2) Money Flow Volume = Money Flow Multiplier x Volume for the Period;
3) 20-period CMF = 20-period Sum of Money Flow Volume / 20 period Sum of Volume;
PROFILE: Myx (MYX.AX)
Stock Exchange: ASX
Ticker Codes: | MYX.AX | ASX:MYX |
Mayne Pharma Group Limited manufactures and sells branded and generic pharmaceutical products worldwide. It operates through four segments: Generic Products, Specialty Brands, Metrics Contract Services, and Mayne Pharma International. The company provides pharmaceuticals in the forms of tablets, capsules, foams, creams, powders, patches, pastes, and gels. It also manufactures oral solid-dose pharmaceutical products; and offers contract analytical and pharmaceutical development, and manufacturing services to third-party customers. The company was formerly known as Halcygen Pharmaceuticals Limited and changed its name to Mayne Pharma Group Limited in November 2010. Mayne Pharma Group Limited is based in Salisbury South, Australia.
|LNG Liquefied Natural Gas||0.3||25.5||6,662,815||-0.3||BEARISH|
|DCN Dacian Gold||0.95||22.6||7,221,770||-0.18||BEARISH|
|RFG Retail Food||0.21||13.9||602,168||-0.02||BEARISH|
|EWC Energy World Corporation||0.1||9.2||682,001||-0.36||BEARISH|
|RMS Ramelius Resources||0.86||8.2||7,633,542||-0.23||BEARISH|
|SDA Speedcast International||1.92||6.7||5,078,109||-0.48||BEARISH|
|CCV Cash Converters International||0.16||6.7||696,944||-0.11||BEARISH|
|CDV Cardinal Resources||0.37||5.7||766,151||-0.39||BEARISH|
|AFL ASX 50||0.2||5.4||164,523||-0.04||BEARISH|